CS160139B2 - - Google Patents

Info

Publication number
CS160139B2
CS160139B2 CS1794A CS179471A CS160139B2 CS 160139 B2 CS160139 B2 CS 160139B2 CS 1794 A CS1794 A CS 1794A CS 179471 A CS179471 A CS 179471A CS 160139 B2 CS160139 B2 CS 160139B2
Authority
CS
Czechoslovakia
Application number
CS1794A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS160139B2 publication Critical patent/CS160139B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CS1794A 1970-03-20 1971-03-11 CS160139B2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2013431A DE2013431C3 (de) 1970-03-20 1970-03-20 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester

Publications (1)

Publication Number Publication Date
CS160139B2 true CS160139B2 (fr) 1975-02-28

Family

ID=5765765

Family Applications (2)

Application Number Title Priority Date Filing Date
CS1794A CS160139B2 (fr) 1970-03-20 1971-03-11
CS3638*A CS160140B2 (fr) 1970-03-20 1971-03-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS3638*A CS160140B2 (fr) 1970-03-20 1971-03-11

Country Status (16)

Country Link
US (2) US3708489A (fr)
JP (1) JPS5521032B1 (fr)
AT (1) AT303040B (fr)
BE (1) BE764556A (fr)
CH (1) CH559179A5 (fr)
CS (2) CS160139B2 (fr)
DE (1) DE2013431C3 (fr)
FI (1) FI54295C (fr)
FR (1) FR2085727B1 (fr)
GB (1) GB1305795A (fr)
IE (1) IE35233B1 (fr)
IL (1) IL36320A (fr)
NL (1) NL169468C (fr)
NO (1) NO131986C (fr)
SE (1) SE364710B (fr)
ZA (1) ZA711597B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
US4021434A (en) * 1972-01-22 1977-05-03 Yamanouchi Pharmaceutical Co., Ltd. Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
US3985886A (en) * 1972-03-06 1976-10-12 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DD106832A5 (fr) * 1972-03-06 1974-07-05
US3992545A (en) * 1972-03-06 1976-11-16 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives in pharmaceutical compositions
US3860601A (en) * 1972-03-06 1975-01-14 Horst Meyer 2,6-diamino-1,4-dihydropyridine derivatives
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3957998A (en) * 1972-03-06 1976-05-18 Bayer Aktiengesellschaft Use of 2,6-diamino-4-substituted-1,4-dihydropyridine-3,5-dicarboxylic acid esters for effecting coronary vessel dilation and treating hypertension
US3857849A (en) * 1973-02-28 1974-12-31 Bayer Ag 2-amino-1,4-dihydropyridine derivatives
US3939171A (en) * 1972-03-06 1976-02-17 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3917620A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
US3974275A (en) * 1972-04-18 1976-08-10 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters useful as coronary vessel dilators and anti-hypertensives
US3996234A (en) * 1972-04-18 1976-12-07 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
DE2239815C2 (de) * 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US4136187A (en) * 1972-08-12 1979-01-23 Bayer Aktiengesellschaft Antihypertensive 2-amino-4,5-dihydropyridine derivatives
DE2242787C2 (de) * 1972-08-31 1982-01-21 Bayer Ag, 5090 Leverkusen 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
US4020178A (en) * 1973-07-12 1977-04-26 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters used as coronary dilators and anti-hypertensives
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (fr) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. Dérivés de 1,4-dihydropyridine utiles contre les cellules tumorales

Also Published As

Publication number Publication date
ZA711597B (en) 1972-06-28
FI54295B (fi) 1978-07-31
NO131986B (fr) 1975-05-26
AT303040B (de) 1972-11-10
BE764556A (fr) 1971-09-20
IL36320A0 (en) 1971-05-26
FI54295C (fi) 1978-11-10
SE364710B (fr) 1974-03-04
NL169468B (nl) 1982-02-16
JPS5521032B1 (fr) 1980-06-06
NL169468C (nl) 1982-07-16
SU365069A3 (fr) 1972-12-28
FR2085727A1 (fr) 1971-12-31
FR2085727B1 (fr) 1974-09-27
GB1305795A (fr) 1973-02-07
NL7103672A (fr) 1971-09-22
US3708489A (en) 1973-01-02
IL36320A (en) 1974-10-22
IE35233L (en) 1971-09-20
CS160140B2 (fr) 1975-02-28
DE2013431B2 (de) 1979-04-26
DE2013431A1 (de) 1971-10-07
US3773956A (en) 1973-11-20
IE35233B1 (en) 1975-12-24
DE2013431C3 (de) 1979-12-20
NO131986C (fr) 1975-09-03
CH559179A5 (fr) 1975-02-28

Similar Documents

Publication Publication Date Title
AU1473870A (fr)
AU2044470A (fr)
AU2130570A (fr)
AU1336970A (fr)
AU1517670A (fr)
AU1833270A (fr)
AU2017870A (fr)
AU2085370A (fr)
AU1841070A (fr)
AU1969370A (fr)
AU1328670A (fr)
AU1086670A (fr)
ATA672271A (fr)
AU1343870A (fr)
AU1581370A (fr)
AU2144270A (fr)
AU2131570A (fr)
AU2130770A (fr)
AU1591370A (fr)
AU2119370A (fr)
AU1603270A (fr)
AU2115870A (fr)
AU2112570A (fr)
AU2061170A (fr)
AU1832970A (fr)